Blood astrocyte biomarkers in AD: a systematic review and meta‐analysis
Sarah Holper, Paula M Loveland, Leonid Churilov, Dominic Italiano, Rosie Watson, Nawaf Yassi · 2025
Read Blood astrocyte biomarkers in AD: a systematic review and meta‐analysis by Sarah Holper, Paula M Loveland, Leonid Churilov, Dominic Italiano, Rosie Watson, Nawaf Yassi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715777.txt.
Description
Sarah Holper and five co-authors carried out a review of studies on blood markers tied to astrocytes, a type of support cell in the brain, in Alzheimer's disease. The team searched two large databases and pooled the results from studies that measured three markers in the blood of patients and of people without memory problems.
Thirty-six studies met the rules for inclusion, covering more than three thousand patients. Two of the markers, named GFAP and YKL-40, were clearly higher in the blood of people with the disease than in healthy controls. The third marker, S100B, showed no clear difference between the groups. The authors note that the gap for the first two markers tended to grow as the disease advanced. Their findings support the idea that simple blood tests could help track changes in the brain linked to this illness.
Catalog record
| CREATOR | Sarah Holper, Paula M Loveland, Leonid Churilov, Dominic Italiano, Rosie Watson, Nawaf Yassi |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |